Wegovy Shortage 2024 News. Wegovy and ozempic—an identical drug, called semaglutide, licensed to treat diabetes and sold under a different brand name—have helped turbocharge growth at novo and. Some dosages of zepbound are in limited supply.
The u.k.’s health regulator on tuesday approved the use of novo nordisk’s wegovy weight loss drug to reduce the risk of overweight and obese adults suffering from serious heart. The fulfilment of various customary closing conditions is progressing, and novo nordisk expects that the acquisition will be completed towards the end of 2024.